Establishing Oprm1 Exon 7-associated Variants as Novel Therapeutic Targets for Mitigating Adverse Effects of Clinically Used MU Opioids without Altering Analgesia in Pain Management
Principal Investigator: Ying-xian Pan
Affiliation: Professor, Department of Anesthesiology, New Jersey Medical School, Rutgers-Health
Amount: $709,572
Sponsor: National Institute on Drug Abuse
